These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

5947 related items for PubMed ID: 12068308

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Different effects of point mutations within the B-Raf glycine-rich loop in colorectal tumors on mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase and nuclear factor kappaB pathway and cellular transformation.
    Ikenoue T, Hikiba Y, Kanai F, Aragaki J, Tanaka Y, Imamura J, Imamura T, Ohta M, Ijichi H, Tateishi K, Kawakami T, Matsumura M, Kawabe T, Omata M.
    Cancer Res; 2004 May 15; 64(10):3428-35. PubMed ID: 15150094
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant.
    Tsavachidou D, Coleman ML, Athanasiadis G, Li S, Licht JD, Olson MF, Weber BL.
    Cancer Res; 2004 Aug 15; 64(16):5556-9. PubMed ID: 15313890
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Raf proteins and cancer: B-Raf is identified as a mutational target.
    Mercer KE, Pritchard CA.
    Biochim Biophys Acta; 2003 Jun 05; 1653(1):25-40. PubMed ID: 12781369
    [Abstract] [Full Text] [Related]

  • 7. Sequencing analysis of BRAF mutations in human cancers.
    Wooster R, Futreal AP, Stratton MR.
    Methods Enzymol; 2006 Jun 05; 407():218-24. PubMed ID: 16757326
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. C-Raf inhibits MAPK activation and transformation by B-Raf(V600E).
    Karreth FA, DeNicola GM, Winter SP, Tuveson DA.
    Mol Cell; 2009 Nov 13; 36(3):477-86. PubMed ID: 19917255
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Functional analysis of mutations within the kinase activation segment of B-Raf in human colorectal tumors.
    Ikenoue T, Hikiba Y, Kanai F, Tanaka Y, Imamura J, Imamura T, Ohta M, Ijichi H, Tateishi K, Kawakami T, Aragaki J, Matsumura M, Kawabe T, Omata M.
    Cancer Res; 2003 Dec 01; 63(23):8132-7. PubMed ID: 14678966
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation.
    Satyamoorthy K, Li G, Gerrero MR, Brose MS, Volpe P, Weber BL, Van Belle P, Elder DE, Herlyn M.
    Cancer Res; 2003 Feb 15; 63(4):756-9. PubMed ID: 12591721
    [Abstract] [Full Text] [Related]

  • 14. The T1796A mutation of the BRAF gene is absent in Spitz nevi.
    Palmedo G, Hantschke M, Rütten A, Mentzel T, Hügel H, Flaig MJ, Yazdi AS, Sander CA, Kutzner H.
    J Cutan Pathol; 2004 Mar 15; 31(3):266-70. PubMed ID: 14984580
    [Abstract] [Full Text] [Related]

  • 15. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.
    Kim PN, Jonasch E, Mosterman BC, Mier JW, Janssen RA.
    Cell Growth Differ; 2001 Nov 15; 12(11):543-50. PubMed ID: 11714635
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: role of BRAF mutation and fibroblast growth factor signaling.
    Huntington JT, Shields JM, Der CJ, Wyatt CA, Benbow U, Slingluff CL, Brinckerhoff CE.
    J Biol Chem; 2004 Aug 06; 279(32):33168-76. PubMed ID: 15184373
    [Abstract] [Full Text] [Related]

  • 18. A Raf-1 mutant that dissociates MEK/extracellular signal-regulated kinase activation from malignant transformation and differentiation but not proliferation.
    Dhillon AS, Meikle S, Peyssonnaux C, Grindlay J, Kaiser C, Steen H, Shaw PE, Mischak H, Eychène A, Kolch W.
    Mol Cell Biol; 2003 Mar 06; 23(6):1983-93. PubMed ID: 12612072
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 298.